Cargando…

Targeting HDAC/OAZ1 axis with a novel inhibitor effectively reverses cisplatin resistance in non-small cell lung cancer

Cisplatin yields significant efficacy and is generally used as a frontline therapy for non-small cell lung cancer (NSCLC). However, acquired resistance strongly limits its application. Here, we identified that a novel histone deacetylase (HDAC) inhibitor S11, with P-glycoprotein inhibitory activity,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yuhong, Bao, Xuefei, Ren, Yong, Jia, Lina, Zou, Shenglan, Han, Jian, Zhao, Mengyue, Han, Mei, Li, Hong, Hua, Qixiang, Fang, Yi, Yang, Jingyu, Wu, Chunfu, Chen, Guoliang, Wang, Lihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534535/ https://www.ncbi.nlm.nih.gov/pubmed/31127087 http://dx.doi.org/10.1038/s41419-019-1597-y

Ejemplares similares

OAZ-t/OAZ3 Is Essential for Rigid Connection of Sperm Tails to Heads in Mouse
por: Tokuhiro, Keizo, et al.
Publicado: (2009)

Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer
por: Wang, Wenjing, et al.
Publicado: (2020)

OAZ1 knockdown enhances viability and inhibits ER and LHR transcriptions of granulosa cells in geese
por: Kang, Bo, et al.
Publicado: (2017)

Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity
por: Wang, Lihui, et al.
Publicado: (2017)

Knocking out Ornithine Decarboxylase Antizyme 1 (OAZ1) Improves Recombinant Protein Expression in the HEK293 Cell Line
por: Abaandou, Laura, et al.
Publicado: (2018)

miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells
por: Li, Yong, et al.
Publicado: (2018)

An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer
por: Wang, Wenjing, et al.
Publicado: (2022)

Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment
por: Ma, Jiacheng, et al.
Publicado: (2018)

HDAC6 Inhibition Reverses Cisplatin-Induced Mechanical Hypersensitivity via Tonic Delta Opioid Receptor Signaling
por: Zhang, Jixiang, et al.
Publicado: (2022)

Dual targeting of retinoid X receptor and histone deacetylase with DW22 as a novel antitumor approach
por: Wang, Lihui, et al.
Publicado: (2015)

Targeting the NANOG/HDAC1 axis reverses resistance to PD-1 blockade by reinvigorating the antitumor immunity cycle
por: Oh, Se Jin, et al.
Publicado: (2022)

The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53
por: Hu, Chen, et al.
Publicado: (2020)

Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors
por: Lobo, João, et al.
Publicado: (2020)

Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer
por: Xiao, Xiaoguang, et al.
Publicado: (2015)

LncRNA C9orf139 can regulate the progression of esophageal squamous carcinoma by mediating the miR-661/HDAC11 axis
por: Yang, Xiaojie, et al.
Publicado: (2022)

Gain-of-function mutations in the catalytic domain of DOT1L promote lung cancer malignant phenotypes via the MAPK/ERK signaling pathway
por: Zhang, Jiayu, et al.
Publicado: (2023)

Purification, Characterization and Antitumor Activities of a New Protein from Syngnathus acus, an Officinal Marine Fish
por: Wang, Mengyue, et al.
Publicado: (2011)

YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor
por: Dong, Sheng, et al.
Publicado: (2017)

PD‐0332991 combined with cisplatin inhibits nonsmall cell lung cancer and reversal of cisplatin resistance
por: Liu, Minghui, et al.
Publicado: (2021)

Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer
por: Li, Meng, et al.
Publicado: (2017)

Upregulation of Fas in epithelial ovarian cancer reverses the development of resistance to Cisplatin
por: Yang, Fan, et al.
Publicado: (2015)

A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction
por: Sato, Tadatoshi, et al.
Publicado: (2020)

Cisplatin resistance reversal by disulfiram and caffeine
por: Kadia, Ashish R., et al.
Publicado: (2016)

Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors
por: Rodrigues Moita, Ana J., et al.
Publicado: (2020)

HDAC6 inhibitor WT161 induces apoptosis in retinoblastoma cells and synergistically interacts with cisplatin
por: Sun, Jun, et al.
Publicado: (2019)

HDAC6 Inhibition Alleviates Ischemia- and Cisplatin-Induced Acute Kidney Injury by Promoting Autophagy
por: Shi, Lang, et al.
Publicado: (2022)

Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines
por: Bandolik, Jan J., et al.
Publicado: (2019)

MCM3AP-AS1 promotes cisplatin resistance in gastric cancer cells via the miR-138/FOXC1 axis
por: Sun, Han, et al.
Publicado: (2021)

Restoration of WT1/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells
por: Bontempi, Giulio, et al.
Publicado: (2022)

SOX2 knockdown with siRNA reverses cisplatin resistance in NSCLC by regulating APE1 signaling
por: Chen, Tai-yu, et al.
Publicado: (2022)

5-Hydroxyindole-Based EZH2 Inhibitors Assembled via TCCA-Catalyzed Condensation and Nenitzescu Reactions
por: Du, Fangyu, et al.
Publicado: (2020)

Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA-374a/forkhead box O1 signaling axis
por: Sun, Yang, et al.
Publicado: (2020)

MBD1/HDAC3-miR-5701-FGFR2 axis promotes the development of gastric cancer
por: Zhao, Changan, et al.
Publicado: (2022)

HDAC10 Inhibits Cervical Cancer Progression through Downregulating the HDAC10-microRNA-223-EPB41L3 Axis
por: Gu, Yuan Yuan, et al.
Publicado: (2022)

The HDAC Inhibitor Phenylbutyrate Reverses Effects of Neonatal Ventral Hippocampal Lesion in Rats
por: Sandner, Guy, et al.
Publicado: (2011)

HDACs Gene Family Analysis of Eight Rosaceae Genomes Reveals the Genomic Marker of Cold Stress in Prunus mume
por: Meng, Juan, et al.
Publicado: (2022)

Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms
por: Wang, L, et al.
Publicado: (2016)

SERPINA3-ANKRD11-HDAC3 pathway induced aromatase inhibitor resistance in breast cancer can be reversed by HDAC3 inhibition
por: Zhou, Jing, et al.
Publicado: (2023)

Increased Glutamine Consumption in Cisplatin-Resistant Cells Has a Negative Impact on Cell Growth
por: Duan, Guihua, et al.
Publicado: (2018)

Dephosphorylation of HDAC4 by PP2A-Bδ unravels a new role for the HDAC4/MEF2 axis in myoblast fusion
por: Veloso, Alexandra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c620m6ii4b181h767lmae14p6i